Clinical studies of Norpace (Part I).
D000284:Administration, Oral; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002214:Capsules; D002986:Clinical Trials as Topic; D004206:Disopyramide / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004562:Electrocardiography; D006801:Humans; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D002214:Capsules; D010919:Placebos; D011725:Pyridines; D004206:Disopyramide